AI-driven approach identifies new targets for drug discovery

Researchers have developed an AI-driven method to identify new targets for human disease, including neurodegenerative conditions such as Alzheimer’s disease. The team, led by the University of Cambridge, presented an approach to identify therapeutic targets for human diseases associated with…









